Vox Sang. 1990;59(3):129-35.

Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study Group.

Dietrich SL, Mosley JW, Lusher JM, Hilgartner MW, Operskalski EA, Habel L, Aledort LM, Gjerset GF, Koerper MA, Lewis BH, et al.

Source

University of Southern California, Los Angeles.

Abstract

The Transfusion Safety Study monitored susceptible persons for human immunodeficiency virus type 1 (HIV-1) infections transmitted by plasma products and blood components. Through December, 1988, 6 subjects without antibody to HIV-1 (anti-HIV-1) became seropositive after receiving dry-heated factor VIII concentrate. The preparations implicated in 3 cases were derived entirely from anti-HIV-1-screened donors. In all instances, HIV-1 infection could be explained by concentrates heated at 60 degrees C for 24-30 h. Limiting consideration to concentrates and components administered after study entry showed that 4 of the seroconversions occurred among 122 subjects given 10 million units of factor VIII concentrates. No seroconversions occurred among 84 subjects given 5 million units of factor IX concentrates, or 83 who received components from over 26,000 unpaid donations. Serologic surveillance of anti-HIV-1-negative subjects provides important information, and should be routine in the management of persons receiving clotting factor concentrates.

PMID:: 2124751; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Save items

Related citations in PubMed

Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group. [Transfusion. 1995]
Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group.
Shapiro A, Abe T, Aledort LM, Anderle K, Hilgartner MW, Kunschak M, Preston FE, Rivard GE, Schimpf K. Transfusion. 1995 Mar; 35(3):204-8.
Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III. [Med J Aust. 1985]
Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III.
McGrath KM, Thomas KB, Herrington RW, Turner PJ, Taylor L, Ekert H, Schiff P, Gust ID. Med J Aust. 1985 Jul 8; 143(1):11-3.
HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate. [CMAJ. 1990]
HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.
Remis RS, O'Shaughnessy MV, Tsoukas C, Growe GH, Schechter MT, Palmer RW, Lawrence DN. CMAJ. 1990 Jun 1; 142(11):1247-54.
Review Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States? [Vox Sang. 1994]
Review Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States?
Mosley JW. Vox Sang. 1994; 67 Suppl 4:12-5; discussion 24-6.
Review Current safety of clotting factor concentrates. [Arch Pathol Lab Med. 1990]
Review Current safety of clotting factor concentrates.
Epstein JS, Fricke WA. Arch Pathol Lab Med. 1990 Mar; 114(3):335-40.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Transmission of human immunodeficiency virus type 1 by dry-heated clotting facto...
Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study Group.
Vox Sang. 1990 ;59(3):129-35.

PubMed
Animal products, diseases and drugs: a plea for better integration between agric...
Animal products, diseases and drugs: a plea for better integration between agricultural sciences, human nutrition and human pharmacology.
Lipids Health Dis. 2011 Jan 20 ;10:16.

PubMed
The association of remotely-sensed outdoor temperature with blood pressure level...
The association of remotely-sensed outdoor temperature with blood pressure levels in REGARDS: a cross-sectional study of a large, national cohort of African-American and white participants.
Environ Health. 2011 Jan 19 ;10(1):7.

PubMed
Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box ele...
Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription.
Proc Natl Acad Sci U S A. 1990 Dec ;87(24):9990-4.

PubMed
Catalytic mechanism and three-dimensional structure of adenine deaminase.
Catalytic mechanism and three-dimensional structure of adenine deaminase.
Biochemistry. 2011 Mar 22 ;50(11):1917-27. Epub 2011 Feb 4 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: